Germline PALB2 Mutation in High-Risk Chinese Breast and/or Ovarian Cancer Patients
Open Access
Abstract
The prevalence of the PALB2 mutation in breast cancer varies across different ethnic groups; hence, it is of intense interest to evaluate the cancer risk and clinical association of the PALB2 mutation in Chinese breast and/or ovarian cancer patients. We performed sequencing with a 6-gene test panel (BRCA1, BRCA2, TP53, PTEN, PALB2, and CDH1) to identify the prevalence of the PALB2 germline mutation among 2631 patients with breast and/or ovarian cancer. In this cohort, 39 mutations were identified with 24 types of mutation variants, where the majority of the mutations were frame-shift mutations and resulted in early termination. We also identified seven novel PALB2 mutations. Most of the PALB2 mutation carriers had breast cancer (36, 92.3%) and were more likely to have family history of breast cancer (19, 48.7%). The majority of the breast tumors were invasive ductal carcinoma (NOS type) (34, 81.0%) and hormonal positive (ER: 32, 84.2%; PR: 23, 60.5%). Pathogenic mutations of PALB2 were found in 39 probands with a mutation frequency of 1.6% and 1% in breast cancer and ovarian cancer patients, respectively. PALB2 mutation carriers were more likely have hormonal positive tumors and were likely to have familial aggregation of breast cancer.Keywords
Funding Information
- Health and Medical Research Fund (03143406)
This publication has 41 references indexed in Scilit:
- The BRCA2 c.9004G>A (E2003K) variant is likely pathogenic and recurs in breast and/or ovarian cancer families of French Canadian descentBreast Cancer Research and Treatment, 2011
- A PALB2 mutation associated with high risk of breast cancerBreast Cancer Research, 2010
- KIAA1018/FAN1 nuclease protects cells against genomic instability induced by interstrand cross-linking agentsProceedings of the National Academy of Sciences, 2010
- PALB2 mutations in European familial pancreatic cancer familiesClinical Genetics, 2010
- The Breast Cancer Susceptibility Mutation PALB2 1592delT Is Associated with an Aggressive Tumor PhenotypeClinical Cancer Research, 2009
- Penetrance Analysis of the PALB2 c.1592delT Founder MutationClinical Cancer Research, 2008
- Identification of a novel truncating PALB2mutation and analysis of its contribution to early-onset breast cancer in French-Canadian womenBreast Cancer Research, 2007
- Analysis ofPALB2/FANCN-associated breast cancer familiesProceedings of the National Academy of Sciences, 2007
- A recurrent mutation in PALB2 in Finnish cancer familiesNature, 2007
- PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility geneNature Genetics, 2006